DA
LLY icon

DCF Advisers’s Eli Lilly LLY Stock Holding History

DCF Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,500
Closed -$578K – 81
2021
Q3 		$578K Buy
+2,500
New +$617K 0.26% 60

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

DCF Advisers's LLY Position: Q1 2026 in Review

DCF Advisers held its Eli Lilly (LLY) position steady in Q1 2026 at 8,300 shares worth $7.63M. The position accounts for 2.04% of the portfolio, ranked #11.

DCF Advisers first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.92M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • DCF Advisers held 8,300 shares of Eli Lilly worth $7.63M as of Q1 2026.
  • DCF Advisers left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 2.04% of DCF Advisers's portfolio in Q1 2026, its #11 holding.
  • DCF Advisers first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • DCF Advisers's Eli Lilly position peaked at $8.92M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.